• Multaq®
• Dronedarone
• Multaq® 400 mg
• Multaq® and Atrial Fibrillation
• Multaq® Dosage
• Multaq® Drug
• Multaq® Drug Interactions
• Multaq® Heart Failure
• Multaq® Heart Medication
• Multaq® Hepatic Injury
• Multaq® Injury
• Multaq® Kidney Failure
• Multaq® Lawsuit
• Multaq® Lawyer
• Multaq® Liver Failure
• Multaq® Liver Injury: FDA Warning
• Multaq® Liver Injury Lawsuit
• Multaq® Liver Injury Lawyer
• Multaq® Liver Toxicity
• Multaq® Side Effects
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Multaq® (dronedarone) is a prescription medication to treat atrial fibrillation and atrial flutter. Both conditions are abnormal heart rhythms. Atrial fibrillation is an irregular heartbeat. Atrial flutter is a regular heartbeat that is beating too rapidly.

The medication is given to patients with these conditions to regulate their heartbeat and keep them from needing hospitalization. It is also given to patients who will be cardioverted (their hearts will be shocked to restore a normal rhythm).

Multaq® heart medication comes as a 400 mg white tablet which should be taken twice daily, once with breakfast and once with dinner. Manufactured by French drug maker Sanofi-Aventis, the medicine was approved by the U.S. Food and Drug Administration (FDA) in July 2009. Because of many adverse effects in a short period of time, the medication has been controversial.

A report released by the Institute for Safe Medication Practices, said the drug was linked to cases of heart failure, deadly irregular heartbeats, adverse drug interactions, and impaired kidney function. The report said Multaq had been associated with 387 cases of adverse events since the drug's approval in July last year.

Medications to Avoid When Taking Multaq®

Patients taking Multaq® should not eat grapefruit or drink grapefruit juice because of potentially dangerous interactions with the drug.

Some drugs that might interact with Multaq® and should be avoided when taking the medication include:

• Blood thinners
• Cyclosporine
• Digoxin
• Sirolimus or tacrolimus
• St. John's wort
• Theophylline
• Tuberculosis medication
• Certain beta blockers
• Cholesterol lowering drugs
• Blood pressure medication
• Seizure medication

Names of some drugs that should not be taken with Multaq® are:

• Amiodarone
• Arsenic Trioxide
• Astemizole
• Atazanavir
• Azithromycin
• Cisapride
• Clarithromycin
• Cyclosporine
• Disopyramide
• Dofetilide
• Droperidol
• Erythromycin
• Gatifloxacin
• Halofantrine
• Ibutilide
• Indinavir
• Itraconazole
• Ketoconazole
• Levofloxacin
• Mefloquine
• Methadone
• Moxifloxacin
• Nefazodone
• Nelfinavir
• Paliperidone
• Pimozide
• Procainamide
• Quinidine
• Quinine
• Ritonavir
• Saquinavir
• Sodium Phosphate
• Sotalol
• Telavancin
• Telithromycin
• Terfenadine
• Thioridazine
• Vardenafil
• Voriconazole
• Ziprasidone

This is only a partial list of the 477 drugs that Multaq® is interacts adversely with.

Contact a Multaq® Lawyer

Have you experienced heart failure, deadly irregular heartbeats, adverse drug interactions or impaired kidney function while taking Multaq®? If so, our Multaq® heart medication lawyers may be able to help you recover compensation. Contact us for more information.

"FDA Alert: Multaq® Linked to Liver Failure"

The FDA notified healthcare professionals about new findings that link Multaq® to severe liver injuries, Jan. 14, 2011. The agency said there were two report...

» Read More